The Department of Health and Human Services Food and Drug Administration (FDA) awarded a 5-year, $99 million single-award Blanket Purchase Agreement (BPA) under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle to Deloitte Consulting LLP, doing business as Deloitte. The BPA is for the FDA's Center for Drug Evaluation and Research (CDER) Office of Business Informatics (OBI) to obtain drug supply chain management services and related analytics.
As the prime contractor, Deloitte will provide professional services to support the FDA's drug supply chain operations, including program management, IT modernization, data analytics, and other specialized consulting. This BPA continues Deloitte's history of delivering mission-critical services to federal agencies like the Departments of Health and Human Services, Homeland Security, Defense, Treasury, and Veterans Affairs through prime contracts and subcontracts. The BPA has a period of performance from March 19, 2024 to March 19, 2029.
Generated 3/21/24, 9:18 AM